Â鶹´«Ã½¸ßÇå°æ

• MSc: Public Health and Health Promotion
  2021–2022
• Other: Doctor of Pharmacy (Pharmaceutical Care)
  Chiang Mai University, 2018

2024

• Published
  Meades, R., Moran, P., Hutton, U., Khan, R., Maxwell, M., Cheyne, H., Delicate, A., Shakespeare, J., Hollins, K., Pisavadia, K., Doungsong, P., Edwards, R. T., Sinesi, A. & Ayers, S., 7 Nov 2024, In: Frontiers in Public Health. 12, p. 1466150 11 p., 1466150.
  Research output: Contribution to journal › Article › peer-review
• Published
  Doungsong, P., Hartfiel, N. & Edwards, R. T., 23 Apr 2024, In: INQUIRY: The Journal of Health Care Organization, Provision, and Financing. 61, p. 469580241246468
  Research output: Contribution to journal › Article › peer-review
• Published
  Doungsong, P., To Kwong, H., Hartfiel, N., Sandinha, D. T., Steel, P. D. & Edwards, R. T., 7 Aug 2024, NIHR PROSPERO (International Prospective Register of Systematic Reviews).
  Research output: Other contribution › peer-review

2023

• Published
  Doungsong, P., Edwards, R. T. & Hartfiel, N., 25 Aug 2023, MedRxiv.
  Research output: Working paper › Preprint
• Published
  O'Toole, S., Moazzez, R., Wojewodka, G., Zeki, S., Jafari, J., Brand, A., Hoare, Z., Scott, S., Doungsong, P., Ezeofor, V., Edwards, R. T., Drakatos, P. & Steier, J., 24 Aug 2023, In: BMJ Open. 13, 8, p. e076661 e076661.
  Research output: Contribution to journal › Article › peer-review

2021

• Published
  Doungsong, P., Chinwong, S., Channaina, P., Chinwong, D. & Phrommintikul, A., Sept 2021, In: Research in Social and Administrative Pharmacy . 17, 9, p. 1631-1635
  Research output: Contribution to journal › Article › peer-review

2024

• This cost-consequence analysis accompanies the FEMuR III randomised controlled trial using a micro-costing approach. The main outcome measures in this economic evaluation were healthcare service use, costs and quality of life over 12 months, from both National Health Service and wider societal perspectives. Quality of life was measured using the EuroQoL-5D-3L.

  20 Nov 2024

  Links:

  Activity: Oral presentation (Speaker)

2023

• Background Regular exercise and community engagement may slow the rate of function loss for people with dementia. However, the evidence is uncertain regarding the cost-effectiveness and social return on investment (SROI) of home exercise with community referral for people with dementia. This study aimed to compare the social value generated from the in-person PrAISED programme delivered before March 2020 with a blended PrAISED programme delivered after March 2020.

  Methods SROI analysis was conducted alongside a randomised controlled trial (RCT). Of 205 patient participants and their carers who completed cost data, 61 completed an in-person programme before March 2020. Due to COVID-19 pandemic restrictions, 144 patient participants completed a blended programme consisting of a combination of in-person visits, phone calls and video conferencing with multidisciplinary team (MDT) members.

  SROI analysis compared in-person and blended delivery formats. Five relevant and material outcomes were identified: three outcomes for patient participants (fear of falling, health-related quality of life, and social connection); one outcome for carer participants (carer strain index), and one outcome for the NHS (health service resource use). Data were collected at baseline and a 12-month follow-up.

  Results The in-person PrAISED programme generated SROI ratios ranging from £0.58 to £2.33 for every £1 invested. In-person PrAISED patient participants gained social value from improved health-related quality of life, social connection, and less fear of falling. In-person PrAISED carer participants acquired social value from less carer strain. The NHS gained benefit from less health care service resource use. However, the blended PrAISED programme generated lower SROI ratios ranging from a negative ratio to £0.08: £1.

  Conclusion Compared with the blended programme, the PrAISED in-person programme generated higher SROI ratios for people with early dementia. During the COVID-19 pandemic and its restrictions, a blended delivery of the programme and the curtailment of community activities resulted in lower SROI ratios during this period. An in-person PrAISED intervention with community referral is likely to provide better value for money than a blended one with limited community referral, despite the greater costs of the former.

  28 Aug 2023 – 1 Sep 2023

  Links:

  Activity: Invited talk (Speaker)

• Oral presentation at the HESG meeting summer 2023

  21 Jun 2023 – 23 Jun 2023

  Activity: Oral presentation (Speaker)

• Poster presentation: Home exercise and community referral for people with early dementia: Social Return On Investment comparing in-person and blended programmes.

  10 Jan 2023

  Activity: Participation in Academic conference (Speaker)